10-Q |
Report
| Data |
10-Q |
Nov 5, 2024 |
Sep 30, 2024 |
SC 13G |
Report
|
|
Oct 18, 2024 |
|
8-K |
Report
| Data |
8-K |
Aug 8, 2024 |
Aug 8, 2024 |
10-Q |
Report
| Data |
10-Q |
Aug 1, 2024 |
Jun 30, 2024 |
8-K |
Report
| Data |
8-K |
Jun 5, 2024 |
Jun 5, 2024 |
8-K |
Report
| Data |
8-K |
May 14, 2024 |
May 13, 2024 |
10-Q |
Report
| Data |
10-Q |
May 7, 2024 |
Mar 31, 2024 |
10-K/A |
Report
| Data |
10-K/A |
Feb 29, 2024 |
Dec 31, 2023 |
8-K |
Report
| Data |
8-K |
Feb 27, 2024 |
Feb 27, 2024 |
10-K |
Report
| Data |
10-K |
Feb 27, 2024 |
Dec 31, 2023 |
SC 13G/A |
Report
|
|
Feb 14, 2024 |
|
SC 13G |
Report
|
|
Feb 14, 2024 |
|
SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 13, 2024 |
|
SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 8, 2024 |
|
8-K |
Report
| Data |
8-K |
Jan 22, 2024 |
Jan 16, 2024 |
8-K |
Report
| Data |
8-K |
Jan 8, 2024 |
Jan 8, 2024 |
8-K |
Report
| Data |
8-K |
Dec 14, 2023 |
Dec 14, 2023 |
8-K |
Report
| Data |
8-K |
Dec 1, 2023 |
Nov 30, 2023 |
8-K |
Report
| Data |
8-K |
Nov 1, 2023 |
Oct 31, 2023 |
10-Q |
Report
| Data |
10-Q |
Nov 1, 2023 |
Sep 30, 2023 |
8-K |
Report
| Data |
8-K |
Oct 5, 2023 |
Oct 5, 2023 |
SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Sep 8, 2023 |
|
8-K |
Report
| Data |
8-K |
Aug 29, 2023 |
Aug 28, 2023 |
8-K |
Report
| Data |
8-K |
Aug 22, 2023 |
Aug 22, 2023 |
10-Q |
Report
| Data |
10-Q |
Jul 31, 2023 |
Jun 30, 2023 |
8-K |
Report
| Data |
8-K |
Jul 31, 2023 |
Jul 31, 2023 |
SC 13G |
Report
|
|
Jul 18, 2023 |
|
8-K |
Report
| Data |
8-K |
Jul 17, 2023 |
Jul 15, 2023 |
SC 13G/A |
Report
|
|
Jul 7, 2023 |
|
8-K |
Report
| Data |
8-K |
Jun 1, 2023 |
Jun 1, 2023 |
10-Q |
Report
| Data |
10-Q |
May 4, 2023 |
Mar 31, 2023 |
8-K |
Report
| Data |
8-K |
Mar 15, 2023 |
Mar 15, 2023 |
8-K |
Report
| Data |
8-K |
Feb 24, 2023 |
Feb 22, 2023 |
10-K |
Report
| Data |
10-K |
Feb 21, 2023 |
Dec 31, 2022 |
SC 13G |
Report
|
|
Feb 14, 2023 |
|
SC 13G/A |
Report
|
|
Feb 14, 2023 |
|
SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 9, 2023 |
|
SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 6, 2023 |
|
SC 13G/A |
Report
|
|
Feb 1, 2023 |
|
8-K |
Report
| Data |
8-K |
Jan 9, 2023 |
Jan 9, 2023 |
8-K |
Report
| Data |
8-K |
Jan 5, 2023 |
Jan 3, 2023 |
10-Q |
Report
| Data |
10-Q |
Nov 7, 2022 |
Sep 30, 2022 |
8-K |
Report
| Data |
8-K |
Aug 24, 2022 |
Aug 24, 2022 |
10-Q |
Report
| Data |
10-Q |
Aug 8, 2022 |
Jun 30, 2022 |
8-K |
Report
| Data |
8-K |
Aug 2, 2022 |
Jul 28, 2022 |
8-K |
Report
| Data |
8-K |
Jul 27, 2022 |
Jul 26, 2022 |
8-K |
Report
| Data |
8-K |
Jul 19, 2022 |
Jul 19, 2022 |
8-K |
Report
| Data |
8-K |
Jun 2, 2022 |
Jun 1, 2022 |
10-Q |
Report
| Data |
10-Q |
May 4, 2022 |
Mar 31, 2022 |
8-K |
Report
| Data |
8-K |
Mar 25, 2022 |
Mar 23, 2022 |
8-K |
Report
| Data |
8-K |
Mar 16, 2022 |
Mar 16, 2022 |
10-K |
Report
| Data |
10-K |
Feb 28, 2022 |
Dec 31, 2021 |
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2022 |
|
SC 13G |
Report
|
|
Feb 14, 2022 |
|
SC 13G |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 9, 2022 |
|
SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 4, 2022 |
|
SC 13G/A |
Report
|
|
Feb 3, 2022 |
|
8-K |
Report
| Data |
8-K |
Jan 20, 2022 |
Jan 20, 2022 |
8-K |
Report
| Data |
8-K |
Jan 10, 2022 |
Jan 10, 2022 |
8-K |
Report
| Data |
8-K |
Nov 17, 2021 |
Nov 15, 2021 |
10-Q |
Report
| Data |
10-Q |
Nov 8, 2021 |
Sep 30, 2021 |
8-K |
Report
| Data |
8-K |
Sep 9, 2021 |
Sep 9, 2021 |
8-K |
Report
| Data |
8-K |
Aug 30, 2021 |
Aug 24, 2021 |
8-K |
Report
| Data |
8-K |
Aug 19, 2021 |
Aug 13, 2021 |
10-Q |
Report
| Data |
10-Q |
Aug 9, 2021 |
Jun 30, 2021 |
8-K |
Report
| Data |
8-K |
Jul 26, 2021 |
Jul 23, 2021 |
8-K |
Report
| Data |
8-K |
Jul 8, 2021 |
Jul 7, 2021 |
8-K |
Report
| Data |
8-K |
Jun 30, 2021 |
Jun 30, 2021 |
8-K |
Report
| Data |
8-K |
Jun 1, 2021 |
Jun 1, 2021 |
10-Q |
Report
| Data |
10-Q |
Apr 28, 2021 |
Mar 31, 2021 |
8-K |
Report
| Data |
8-K |
Mar 11, 2021 |
Mar 10, 2021 |
10-K |
Report
| Data |
10-K |
Feb 25, 2021 |
Dec 31, 2020 |
SC 13G/A |
Report
|
SC 13G/A |
Feb 16, 2021 |
|
SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 16, 2021 |
|
SC 13G |
Report
|
SCHEDULE 13G |
Feb 10, 2021 |
|
SC 13G/A |
Report
|
|
Feb 5, 2021 |
|
SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 3, 2021 |
|
8-K |
Report
| Data |
8-K |
Jan 26, 2021 |
Jan 26, 2021 |
8-K |
Report
| Data |
8-K |
Jan 7, 2021 |
Jan 6, 2021 |
8-K |
Report
| Data |
8-K |
Jan 4, 2021 |
Dec 30, 2020 |
10-Q |
Report
| Data |
10-Q |
Nov 2, 2020 |
Sep 30, 2020 |
8-K |
Report
| Data |
8-K |
Oct 27, 2020 |
Oct 27, 2020 |
10-Q |
Report
| Data |
10-Q |
Jul 30, 2020 |
Jun 30, 2020 |
8-K |
Report
| Data |
8-K |
Jun 1, 2020 |
Jun 1, 2020 |
8-K |
Report
| Data |
8-K |
May 13, 2020 |
May 12, 2020 |
8-K |
Report
| Data |
8-K |
May 7, 2020 |
May 6, 2020 |
10-Q |
Report
| Data |
10-Q |
Apr 29, 2020 |
Mar 31, 2020 |
8-K |
Report
| Data |
8-K |
Apr 6, 2020 |
Apr 2, 2020 |
10-K |
Report
| Data |
10-K |
Feb 27, 2020 |
Dec 31, 2019 |
SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2020 |
|
SC 13G/A |
Report
|
|
Feb 14, 2020 |
|
SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 10, 2020 |
|
SC 13G/A |
Report
|
|
Feb 5, 2020 |
|
SC 13G |
Report
|
SEC SCHEDULE 13G |
Jan 28, 2020 |
|
8-K |
Report
| Data |
8-K |
Jan 9, 2020 |
Jan 8, 2020 |
8-K |
Report
| Data |
8-K |
Jan 7, 2020 |
Jan 7, 2020 |
8-K |
Report
| Data |
8-K |
Jan 7, 2020 |
Jan 7, 2020 |
10-Q |
Report
| Data |
10-Q |
Nov 5, 2019 |
Sep 30, 2019 |
8-K |
Report
| Data |
8-K |
Oct 7, 2019 |
Oct 1, 2019 |
8-K |
Report
| Data |
8-K |
Sep 16, 2019 |
Sep 11, 2019 |
8-K |
Report
| Data |
8-K |
Sep 12, 2019 |
Sep 11, 2019 |
8-K |
Report
| Data |
8-K |
Sep 11, 2019 |
Sep 11, 2019 |
10-Q |
Report
| Data |
10-Q |
Jul 31, 2019 |
Jun 30, 2019 |
8-K |
Report
|
8-K |
Jun 21, 2019 |
Jun 18, 2019 |
8-K |
Report
|
8-K |
Jun 10, 2019 |
Jun 7, 2019 |
SC 13G/A |
Report
|
SC 13G/A |
May 24, 2019 |
|
10-Q |
Report
| Data |
10-Q |
May 7, 2019 |
Mar 31, 2019 |
8-K |
Report
|
8-K |
Apr 12, 2019 |
Apr 8, 2019 |
SC 13G/A |
Report
|
SC 13G/A |
Mar 22, 2019 |
|
SC 13G/A |
Report
|
SC 13G/A |
Mar 13, 2019 |
|
8-K |
Report
|
8-K |
Mar 7, 2019 |
Mar 6, 2019 |
8-K |
Report
|
FORM 8-K |
Mar 4, 2019 |
Mar 4, 2019 |
8-K |
Report
|
8-K |
Feb 28, 2019 |
Feb 28, 2019 |
10-K |
Report
| Data |
10-K |
Feb 26, 2019 |
Dec 31, 2018 |
SC 13G/A |
Report
|
AMENDMENT NO. 2 |
Feb 14, 2019 |
|
SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2019 |
|
SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2019 |
|
SC 13G/A |
Report
|
VENBIO GLOBAL STRATEGIC FUND II, L.P. / APELLIS PHARMACEUTICALS - SCHEDULE 13G/A |
Feb 14, 2019 |
|
SC 13G |
Report
|
SC 13G |
Feb 14, 2019 |
|
SC 13G |
Report
|
|
Feb 8, 2019 |
|
8-K |
Report
|
8-K |
Dec 20, 2018 |
Dec 20, 2018 |
10-Q |
Report
| Data |
10-Q |
Nov 13, 2018 |
Sep 30, 2018 |
8-K |
Report
|
FORM 8-K |
Oct 17, 2018 |
Oct 17, 2018 |
8-K |
Report
|
FORM 8-K |
Sep 4, 2018 |
Sep 4, 2018 |
10-Q |
Report
| Data |
10-Q |
Jul 31, 2018 |
Jun 30, 2018 |
8-K |
Report
|
FORM 8-K |
Jun 5, 2018 |
Jun 4, 2018 |
10-Q |
Report
| Data |
10-Q |
Apr 30, 2018 |
Mar 31, 2018 |
8-K |
Report
|
FORM 8-K |
Apr 2, 2018 |
Mar 30, 2018 |
10-K |
Report
| Data |
10-K |
Mar 19, 2018 |
Dec 31, 2017 |
SC 13G/A |
Report
|
|
Feb 14, 2018 |
|
SC 13G |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2018 |
|
SC 13G |
Report
|
SC 13G |
Feb 14, 2018 |
|
SC 13G |
Report
|
VENBIO GLOBAL STRATEGIC FUND II, L.P. / APELLIS PHARMACEUTICALS - SCHEDULE 13G |
Feb 9, 2018 |
|
SC 13G |
Report
|
SCHEDULE 13G |
Feb 8, 2018 |
|
10-Q |
Report
| Data |
10-Q |
Dec 20, 2017 |
Sep 30, 2017 |
SC 13G |
Report
|
|
Nov 21, 2017 |
|
8-K |
Report
|
FORM 8-K |
Nov 13, 2017 |
Nov 13, 2017 |